Paxman AB (publ) (PAX.ST)
Paxman AB (publ) operates in the Medical - Devices industry of the Healthcare sector, headquartered in Karlshamn, BL, SE. The stock last traded at $61.20, up 2.00% on the session, giving a market capitalisation of $1.42B. Its beta of 0.48 implies it has historically moved less than the broad market.
Paxman AB (publ), along with its subsidiaries, specializes in the creation and worldwide sale of the Paxman scalp cooling system, an innovative solution designed to minimize hair loss in patients undergoing chemotherapy. This system is distributed across Europe, the United States, Mexico, Japan, Oceania, various Asian regions, and both South and Central America, primarily serving cancer centers and hospitals. The company is also engaged in a research collaboration agreement with the National University Hospital in Singapore, working towards the development of a portable cooling and compression device. Established in 1996, Paxman AB (publ) is headquartered in Karlshamn, Sweden.
Paxman AB (publ) is most often compared with the following Healthcare names: